全文获取类型
收费全文 | 2710515篇 |
免费 | 231506篇 |
国内免费 | 22314篇 |
专业分类
耳鼻咽喉 | 36890篇 |
儿科学 | 82251篇 |
妇产科学 | 73448篇 |
基础医学 | 372740篇 |
口腔科学 | 77992篇 |
临床医学 | 251909篇 |
内科学 | 536692篇 |
皮肤病学 | 64680篇 |
神经病学 | 218854篇 |
特种医学 | 107955篇 |
外国民族医学 | 723篇 |
外科学 | 413149篇 |
综合类 | 90395篇 |
现状与发展 | 55篇 |
一般理论 | 861篇 |
预防医学 | 199802篇 |
眼科学 | 62268篇 |
药学 | 203453篇 |
173篇 | |
中国医学 | 16301篇 |
肿瘤学 | 153744篇 |
出版年
2021年 | 26673篇 |
2019年 | 31392篇 |
2018年 | 37551篇 |
2017年 | 32916篇 |
2016年 | 35961篇 |
2015年 | 41726篇 |
2014年 | 53544篇 |
2013年 | 69978篇 |
2012年 | 82573篇 |
2011年 | 88388篇 |
2010年 | 58794篇 |
2009年 | 52983篇 |
2008年 | 77309篇 |
2007年 | 81702篇 |
2006年 | 82687篇 |
2005年 | 80420篇 |
2004年 | 74289篇 |
2003年 | 71628篇 |
2002年 | 68489篇 |
2001年 | 120035篇 |
2000年 | 123820篇 |
1999年 | 105272篇 |
1998年 | 31951篇 |
1997年 | 29197篇 |
1996年 | 28753篇 |
1995年 | 28100篇 |
1994年 | 26021篇 |
1993年 | 23808篇 |
1992年 | 82272篇 |
1991年 | 79736篇 |
1990年 | 77186篇 |
1989年 | 74383篇 |
1988年 | 69058篇 |
1987年 | 67963篇 |
1986年 | 64390篇 |
1985年 | 61545篇 |
1984年 | 46605篇 |
1983年 | 39306篇 |
1982年 | 24120篇 |
1979年 | 43124篇 |
1978年 | 31082篇 |
1977年 | 26632篇 |
1976年 | 24238篇 |
1975年 | 26375篇 |
1974年 | 31281篇 |
1973年 | 30154篇 |
1972年 | 28408篇 |
1971年 | 26516篇 |
1970年 | 24687篇 |
1969年 | 23468篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
32.
33.
34.
Discordant Electrocardiogram Left Ventricular Wall Thickness and Strain Findings in Influenza Myocarditis 下载免费PDF全文
Nael Hawwa M.D. Zoran B. Popovic M.D. Ph.D. Hussain A. Isma'eel M.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(12):1880-1884
A 42‐year‐old man presented with a viral prodrome and tested positive for influenza A. He rapidly deteriorated developing cardiogenic shock, rhabdomyolysis, and acute kidney injury. Patient improved 1 week later with supportive measures including vasopressors, inotropes, and an intraaortic balloon pump. We report this case as it highlights the discordance between echocardiographic ventricular wall thickening as a result of myocardial edema, and electrocardiographic findings at presentation, with a reversal in findings at time of resolution. Additionally, there was some suggestion of a regional pattern to the reduced longitudinal strain. 相似文献
35.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
36.
37.
Peng‐fei Lei Shi‐long Su Ling‐yu Kong Cheng‐gong Wang Da Zhong Yi‐he Hu 《Orthopaedic Surgery》2019,11(5):914-920
Three‐dimensional (3D) printing technology, virtual reality, and augmented reality technology have been used to help surgeons to complete complex total hip arthroplasty, while their respective shortcomings limit their further application. With the development of technology, mixed reality (MR) technology has been applied to improve the success rate of complicated hip arthroplasty because of its unique advantages. We presented a case of a 59‐year‐old man with an intertrochanteric fracture in the left femur, who had received a prior left hip fusion. After admission to our hospital, a left total hip arthroplasty was performed on the patient using a combination of MR technology and 3D printing technology. Before surgery, 3D reconstruction of a certain bony landmark exposed in the surgical area was first performed. Then a veneer part was designed according to the bony landmark and connected to a reference registration landmark outside the body through a connecting rod. After that, the series of parts were made into a holistic reference registration instrument using 3D printing technology, and the patient's data for bone and surrounding tissue, along with digital 3D information of the reference registration instrument, were imported into the head‐mounted display (HMD). During the operation, the disinfected reference registration instrument was installed on the selected bony landmark, and then the automatic real‐time registration was realized by HMD through recognizing the registration landmark on the reference registration instrument, whereby the patient's virtual bone and other anatomical structures were quickly and accurately superimposed on the real body of the patient. To the best of our knowledge, this is the first report to use MR combined with 3D printing technology in total hip arthroplasty. 相似文献
38.
39.